Drug-induced hepatitis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[Drug-induced hepatitis (patient information)|here]].''' | |||
{{Drug-induced hepatitis}} | {{Drug-induced hepatitis}} | ||
{{CMG}} | {{CMG}} | ||
| Line 9: | Line 10: | ||
==[[Drug-induced hepatitis causes|Causes]]== | ==[[Drug-induced hepatitis causes|Causes]]== | ||
==[[Drug-induced hepatitis differential diagnosis|Differentiating Drug- | ==[[Drug-induced hepatitis differential diagnosis|Differentiating Drug-Induced Hepatitis from other Diseases]]== | ||
==[[Drug-induced hepatitis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Drug-induced hepatitis epidemiology and demographics|Epidemiology and Demographics]]== | ||
Revision as of 18:44, 1 March 2013
For patient information click here. Template:Drug-induced hepatitis Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Causes
Differentiating Drug-Induced Hepatitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies